Indian companies could reap huge profits with the generic copies of drugs
Indian companies could reap huge profits with the generic copies of
drugs that are set to go off-patent between 2012 and 2016. A snapshot of
what the top six stand to gain.
Indian companies could reap huge profits with the generic copies of drugs that are set to go off-patent between 2012 and 2016. A snapshot of what the top six stand to gain.
Graphic by Santosh Kushwaha
Graphic by Santosh Kushwaha
